Exagen Inc. XGN Common stock, capital shares reserved for future issuance
Common stock, capital shares reserved for future issuance at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Exagen Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s common stock, capital shares reserved for future issuance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s common stock, capital shares reserved for future issuance?
- Exagen Inc. (XGN) reported common stock, capital shares reserved for future issuance of $5.96M in Q4 2025.
- How has Exagen Inc.'s common stock, capital shares reserved for future issuance changed year-over-year?
- Exagen Inc.'s common stock, capital shares reserved for future issuance decreased by 1.4% year-over-year, from $6.04M to $5.96M.
- What is the long-term trend for Exagen Inc.'s common stock, capital shares reserved for future issuance?
- Over 5 years (2020 to 2025), Exagen Inc.'s common stock, capital shares reserved for future issuance has grown at a 9.6% compound annual growth rate (CAGR), from $3.78M to $5.96M.